Arix Bioscience Names Former Smith & Nephew Science Head As Non-Exec

Tue, 17th Dec 2019 16:08

(Alliance News) - Arix Bioscience PLC on Tuesday said Naseem Amin has been appointed as a non-executive director with immediate effect.

In addition, Arix said Franz Humer will be retiring from the board on the same date.

The investment firm said Amin will be a member of the Remuneration Committee.

Amin is currently chief executive of GMP-Orphan and a venture partner at Advent Life Sciences. He previously was chief scientific officer of FTSE 100-listed medical equipment firm Smith & Nephew PLC.

Arix shares were trading 2.5% lower in London on Tuesday afternoon at 112.10 pence each.

By Evelina Grecenko; evelinagrecenko@alliancenews.com

Related Shares

More News

5 Jun 2024 12:03

LONDON MARKET MIDDAY: European blue-chips up ahead of likely rate cuts

(Alliance News) - Stock prices in London were mostly higher at midday on Wednesday, but underperforming their European peers, as markets geared up for...

5 Jun 2024 09:52